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Loss of Cellular K1 Mimics Ribotoxic Stress
INHIBITION OF PROTEIN SYNTHESIS AND ACTIVATION OF THE STRESS KINASES SEK1/MKK4, STRESSACTIVATED PROTEIN KINASE/c-Jun NH2-TERMINAL KINASE 1, AND p38/HOG1 BY PALYTOXIN*
(Received for publication, June 6, 1997, and in revised form, September 5, 1997)

Mihail S. Iordanov and Bruce E. Magun‡
From the Department of Cell and Developmental Biology, Oregon Health Sciences University, Portland, Oregon 97201

Palytoxin is a non-peptide water-soluble marine toxin that is
a potent tumor promoter in the mouse skin carcinogenesis
model (2– 4). Many tumor-promoting compounds that are effective in the skin of carcinogen-initiated mice also produce an
inflammatory reaction (5–15). Inflammatory mediators such as
interleukin-1 (IL-1)1 and tumor necrosis factor-a are potent
* This work was supported by U.S. Public Health Service Grants
CA-39360 and ES-08456. The costs of publication of this article were
defrayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
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1
The abbreviations used are: IL, interleukin; SAPK/JNK, stressactivated protein kinase/c-Jun NH2-terminal kinase; p38/HOG1, mammalian homolog of the S. cerevisiae high osmolarity glycerol response
kinase-1; SEK1/MKK4, SAPK/extracellular signal-regulated kinase-1/
mitogen-activated protein kinase kinase-4; AP-1, activator protein-1;

activators of stress kinases such as SAPK/JNK1 and p38/
HOG1 (for a review, see Ref. 16). Kuroki et al. (17) have shown
that Swiss 3T3 cells exposed to concentrations of palytoxin as
low as 0.1 nM display an abundant activation of the stressactivated kinase SAPK/JNK1. Stimulation of SAPK/JNK1 has
been shown to lead to activation of AP-1, a dimeric transcription factor composed of Jun (c-Jun, JunB, JunD) and Fos (cFos, FosB, Fra-1, Fra-2) family members (for a review, see Ref.
18). SAPK/JNK1 phosphorylates c-Jun at serines 63 and 73 in
its NH2 terminus, thereby increasing the transcription activating potential of AP-1 (19, 20). Stimulation of SAPK/JNK1 also
leads to the phosphorylation and activation of the transcription
factor Elk-1 (21, 22), which operates on the regulatory region of
c-fos (for reviews, see Refs. 23 and 24), and to the phosphorylation of activating transcription factor-2 (25, 26), which, as an
activating transcription factor-2/c-Jun heterodimer, operates
on the promoter of c-jun (27). Thus, SAPK/JNK1 increases
AP-1 activity in the nucleus by activating pre-existing AP-1
complexes and by transcriptionally inducing the expression of
the components of AP-1, c-Jun, and c-Fos.
The cellular effects of palytoxin, which include ionic disequilibria (28 –30), increased production of prostaglandins from
arachidonic acid (31–36), and alterations in the affinity of the
EGF receptor (37–39), have been attributed to the ability of
palytoxin to bind to the Na1/K1-ATPase situated in the plasma
membrane. Direct binding of palytoxin to the Na1/K1-ATPase,
also known as the sodium pump, transforms the pump into a
permanently open ion channel that permits the outward flux of
K1 and the inward flux of Na1 and that is independent of ATP
hydrolysis (28 –30). Conclusive demonstration that palytoxin
acts through the sodium pump has come from heterologous
expression of the sodium pump in Saccharomyces cerevisiae,
which lose intracellular K1 following exposure to palytoxin
(29, 30).
Recently, we reported on the identification of the 28 S ribosomal RNA as a specific sensor for stress induced by a subset of
agents that inhibit protein synthesis (1). Some inhibitors of
translation are strong activators of SAPK/JNK1, whereas other
equally effective inhibitors of translation are unable to activate
SAPK/JNK1. The translational inhibitors that activated
SAPK/JNK1, termed ribotoxic stressors (1), either bind to the
28 S rRNA in the peptidyl transferase center (40) (e.g. anisomycin and blasticidin S) or cause specific damage to 28 S rRNA
(e.g. ricin A chain and a-sarcin) within a conserved loop involved in binding of the elongation factors EF-1 and EF-2 (for a
review, see Ref. 41). Activation of SAPK/JNK1 and of its upstream activator SEK1/MKK4 by this group of ribotoxins can
occur only when ribosomes are actively translating at the time
of exposure to the ribotoxic stressor. Prior inhibition of trans-

GST-Elk-1, glutathione S-transferase/Elk-1 fusion protein; MEM, modified Eagle’s medium; EGF, epidermal growth factor.

3528

This paper is available on line at http://www.jbc.org

Downloaded from http://www.jbc.org/ by guest on October 14, 2016

The tumor promoter palytoxin has been found to activate the stress-activated protein kinase/c-Jun NH2-terminal kinase 1 (SAPK/JNK1), and it also potentiates, as
demonstrated here, the p38/HOG1 mitogen-activated
protein kinase and the upstream activator of SAPK/
JNK1, SEK1/MKK4. In search of possible mechanisms
for both the cytotoxicity and the activation of stress
kinases by palytoxin, we found that palytoxin is a potent
inhibitor of cellular protein synthesis. The inhibition of
translation by palytoxin does not result from its direct
binding to the translational apparatus. We have previously demonstrated that ribotoxic stressors (Iordanov,
M. S., Pribnow, D., Magun, J. L., Dinh, T.-H., Pearson,
J. A., Chen, S. L.-Y., and Magun, B. E. (1997) Mol. Cell.
Biol. 17, 3373–3381) signal the activation of SAPK/JNK1
by binding to or covalently modifying 28 S rRNA in
ribosomes that are active at the time of exposure to the
stressor. Palytoxin acted as a ribotoxic stressor, inasmuch as it required actively translating ribosomes at
the time of exposure to activate SAPK/JNK1. Palytoxin
has been shown to augment ion fluxes by binding to the
Na1/K1-ATPase in the plasma membrane of cells. To
determine whether altered fluxes of either Na1 or K1
could be responsible for the effects of palytoxin on
translation and on activation of SAPK/JNK1, cells were
exposed to palytoxin in modified culture medium in
which a major portion of the Na1 was replaced by either
K1 or by choline1. The substitution of Na1 by K1
strongly inhibited the ability of palytoxin both to inhibit
protein translation and to activate SAPK/JNK1, whereas
the substitution of Na1 by choline1 did not. These results suggest that palytoxin-induced efflux of cellular
K1 mimics ribotoxic stress by provoking both translational inhibition and activation of protein kinases associated with cellular defense against stress.

Palytoxin as a Ribotoxic Stressor

EXPERIMENTAL PROCEDURES

Chemicals, Cytokines, and Ribotoxins—Anisomycin, emetine, D-sorbitol, and choline were from Sigma. IL-1a (recombinant mouse) was
from Genzyme (Cambridge, MA). Palytoxin was from Calbiochem. Anisomycin, emetine, and palytoxin were dissolved in (H3C)2SO. In all the
cases when (H3C)2SO was used as a vehicle, corresponding control cells
received the same amount of the vehicle alone (typically not more than
0.2% (v/v)). D-Sorbitol was dissolved in Dulbecco’s modified Eagle’s
medium (DMEM) as a 3 M stock solution. All radiochemicals were from
NEN Life Science Products.
Cell Culture—Rat-1 cells were maintained as described previously
(43). The derivative cell line FC2-Rat1 has been described by Rodland et
al. (44). All experiments presented here were performed using confluent, quiescent cultures obtained through serum deprivation for typically 24 h. DMEM and MEM were from Life Technologies, Inc.
Immunoprecipitation of SAPK/JNK1 and Extracellular Signal-regulated Kinase and Immunocomplex Kinase Assays—All immunoprecipitations and immunocomplex kinase reactions were performed as described for SAPK/JNK1 in Ref. 1. For immunoprecipitation of SAPK/
JNK1, the antibody sc-474 was used, and for immunoprecipitation of
extracellular signal-regulated kinase 1, the antibody sc-93-G was used
(both from Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Western Blot Analysis of SEK1/MKK4 Phosphorylation—The analysis of threonine 223 phosphorylation of SEK1/MKK4 was performed
with the antibody 9151S, and the analysis of tyrosine 182 phosphorylation of p38/HOG1 was performed with the antibody 9211S (both from
New England BioLabs Inc., Beverly, MA) as described in Ref. 1.
Measurement of Protein Synthesis—Incorporation of [3H]leucine was
performed as described in Ref. 1. Determination of protein synthesis
using FC2-Rat1 cells and a chloramphenicol acetyltransferase (CAT)
assay has been described by Rodland et al. (44). The measurement of
luciferase mRNA translation was performed with the Rabbit Reticulocyte Lysate System (catalog number L4960) as described by the manufacturer (Promega, Madison, WI).
Measurement of Na1/K1-ATPase Activity—The activity of the Na1/
K1-ATPase in membranal preparations from Rat-1 cells was determined as described by Brotherus et al. (51) with modifications. Briefly,

S100 microsomal pellets (20 mg of total protein/experimental point)
were resuspended in 0.6 ml of assay solution (pH 7.2; 0.6 mM EGTA, 156
mM NaCl, 24 mM KCl, 3.6 mM MgCl2, 3.6 mM ATP, 60 mM imidazole, 10
mM Na3N; with or without 0.5 mM ouabain) in the presence of varying
concentrations of palytoxin. After 60 min of incubation at 37 °C, the
reactions were stopped by the addition of 1.5 ml of ice-cold stopping
solution (made by the sequential addition on ice of 21.3 ml of 1 M HCl,
18.3 ml of H2O, 1.29 g of L-ascorbic acid, 2.13 ml of 10% ammonium
molybdate, and 3.3 ml of 20% SDS). After 10 min of incubation on ice,
the color development was achieved by the addition of 1.5 ml of a
solution containing 2% (w/v) sodium meta-arsenite, 2% (w/v) sodium
citrate, and 2% (v/v) glacial acetic acid. After incubation for 10 min at
room temperature, the absorption of the samples was measured at 850
nm, and the amount of Pi in each sample was determined using a
standard containing 50 mM Na3PO4.
PhosphorImager and Statistical Analyses—The quantification of
32
PO32
transferred from ATP onto GST-Elk-1 in experiments meas4
uring SAPK/JNK1 kinase activity was performed using the PhosphorImager apparatus and the IPLab Gely software from Molecular Dynamics (Sunnyvale, CA). Statistical analyses were performed using the
StatViewy software from Abacus Concepts, Inc. (Berkeley, CA).
RESULTS

Activation of SAPK/JNK1, SEK1/MKK4, and p38/HOG1
by Palytoxin—The addition of palytoxin to serum-deprived
Rat-1 cells potently induced the activation of SAPK/JNK1
when examined 30 min later (Fig. 1, A and B). As reported
previously by Kuroki et al. (17), the ability of palytoxin to
activate SAPK/JNK1 was biphasic. At concentrations greater
than 1 nM, cells displayed a decreased responsiveness to palytoxin; concentrations of palytoxin greater than 10 nM were
ineffective in activating SAPK/JNK1.
SEK1/MKK4 is a kinase directly responsible for activation of
SAPK/JNK1 (45– 47). Palytoxin showed the same dose dependence in causing the phosphorylation of SEK1/MKK4 at threonine 223, an event indicative of the activation of this kinase
(48) (Fig. 1A). These data suggest that activation of SAPK/
JNK1 is mediated by kinase-directed signals generated upstream of SEK1/MKK4. Palytoxin showed a similar dose dependence in the activation of p38/HOG1, a member of the
proline-directed stress kinases that bears functional and structural homology to SAPK/JNK1 (Fig. 1A). As previously reported, palytoxin did not induce the activation of the MAP
kinase extracellular signal-regulated kinase 1 (data not
shown).
Translational Inhibition by Palytoxin—Previously we reported that some adverse agents that activate SAPK/JNK1
require ribosomes actively engaged in translation at the the
moment of exposure to do so, while simultaneously inhibiting
protein synthesis. These agents were termed ribotoxic stressors
(1). To determine if it could be acting as a ribotoxic stressor,
palytoxin was tested for its ability to inhibit the incorporation
of [3H]leucine into proteins in Rat-1 cells. Indeed, palytoxin
inhibited the incorporation of [3H]leucine in a dose-dependent
manner (Fig. 1B). The ability of palytoxin to both activate
stress kinases (Fig. 1, A and B) and repress [3H]leucine incorporation (Fig. 1B) became apparent at concentrations of the
toxin that were inhibitory for the Na1/K1-ATPase in membranal preparations isolated from Rat-1 cells (Fig. 1B; see
“Experimental Procedures,” and see below). Because palytoxin
is known to act on membrane-associated functions, we considered the possibility that transport of [3H]leucine into cells is
impaired following exposure to palytoxin. To avoid this potential complication, we applied a method for measuring cellular
protein synthesis that is independent of transport and incorporation of amino acids. A derivative of the parental Rat-1
cells, the cell clone FC2-Rat1 bears a stably integrated CAT
reporter gene under the control of a 1-kilobase promoter sequence of the human c-fos gene (44). The expression of CAT
mRNA is kept at very low levels in quiescent cells, but it can be
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lation by nonactivating agents such as diphtheria toxin, T-2
toxin, pactamycin, or emetine for as little time as 2 min abrogate the ability of the ribotoxic stressors, but not of IL-1a or
osmotic stress, to stimulate SAPK/JNK1 activity. We concluded
that the sensors for ribotoxic damage are ribosomes, which can
transduce signals that activate SEK1/MKK4 and SAPK/JNK1
only when they are translationally active at the time of induced
ribotoxicity. Although many stress signals ultimately converge
to activate the stress kinases, signals arising during ribotoxicity are initially conveyed through a pathway distinct from
those used by IL-1a and osmotic stress (1). The transduction of
stress signals through ribosomes is a feature that eukaryotes
share with prokaryotes, whose ribosomes respond to some
translational inhibitors by recapitulating cellular responses
characteristic of either heat shock or cold shock (42).
In the experiments described here, we found that, like ribotoxic stressors, palytoxin potently inhibited protein synthesis
in the concentration range that leads to activation of the stress
kinases SEK1/MKK4, SAPK/JNK1, and p38/HOG1. Similar to
ribotoxic stressors, the ability of palytoxin to activate SAPK/
JNK1 depended on the presence of actively translating ribosomes at the time of exposure to palytoxin. However, unlike
ribotoxic stressors, palytoxin did not inhibit protein synthesis
as a consequence of direct binding to the translational apparatus. To determine whether the effects of palytoxin on translation and SAPK/JNK1 activation resulted from altered ionic
fluxes, a major portion of the Na1 in the culture medium was
replaced by either K1 or choline1. The substitution of Na1 by
K1, but not by choline1, inhibited the ability of palytoxin both
to inhibit protein translation and to activate SAPK/JNK1, suggesting that the efflux of cellular K1 may be responsible for
both translational inhibition and activation of SAPK/JNK1.
Thus, loss of K1 from stressed cells may lead to the activation
of stress kinases through ribosome-mediated signaling.
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FIG. 1. Palytoxin-induced inhibition of protein synthesis and
activation of the stress kinases SEK1/MKK4, SAPK/JNK1, and
p38/HOG1. A, activation of SAPK/JNK1 and phosphorylation of SEK1/
MKK4 and p38/HOG1 following treatment of Rat-1 cells with palytoxin.
Rat-1 cells (3 3 106) were serum-deprived in DMEM for 24 h prior to
stimulation with palytoxin concentrations as shown. Cells were harvested in lysis buffer 30 min after palytoxin addition, and the activity of
SAPK/JNK1 was determined in immunocomplex assays using an antiSAPK/JNK1 antibody to precipitate SAPK/JNK1 and using GST-Elk-1
recombinant protein to serve as a substrate for phosphorylation (see
“Experimental Procedures”). The phosphorylation states of SEK1/
MKK4 and p38/HOG1 were assessed in Western blots using antibodies
that recognize the respective phosphorylation sites associated with
activation (see “Experimental Procedures”). B, effect of varying concentrations of palytoxin on Na1/K1-ATPase activity, on [3H]leucine incorporation and on SAPK/JNK1 activity. For the Na1/K1-ATPase activity,
membranes isolated from Rat-1 cells (20 mg of total protein) were
incubated in an assay solution (see “Experimental Procedures”) with
the indicated concentrations of palytoxin, in the presence or in the
absence of 0.5 M ouabain at 37 °C. Sixty min later, the reactions were
stopped (see “Experimental Procedures”), and the degree of ATP hydrolysis was determined as described under “Experimental Procedures.” The activity of the Na1/K1-ATPase (defined as the difference
between the total ATPase activities without and with ouabain) in the
absence of palytoxin (indicated as 100% in the graph) was 17 mmol of
hydrolyzed ATP/1 mg of protein/1 h. The values for SAPK/JNK1 activity
were determined following quantitative PhosphorImager analysis of
the data in A (above). The effect of palytoxin on [3H]leucine incorporation into acid-insoluble material was determined in serum-deprived
Rat-1 cells that were pulse-labeled with [3H]leucine (1 mCi/ml) in
DMEM from 15 to 30 min following the addition of palytoxin. C, palytoxin-induced inhibition of CAT mRNA translation in FC2-Rat1 cells.
Serum-deprived cells were stimulated for 2 h with EGF (40 ng/ml) in
the presence of cycloheximide (25 mg/ml). Thereafter, both EGF and
cycloheximide were removed from the medium by extensive washout
(indicated as release, t 5 0 min). The accumulation of CAT protein was
monitored by measuring CAT activity 0, 60, 90, and 120 min after the
release. Palytoxin (1 nM) was applied 60 min after the release (arrow).
Squares represent CAT activity in cells treated at 60 min with solvent
alone; circles represent CAT activity in the palytoxin-treated cells. S.D.
was obtained from experimental points in triplicate.

induced up to 100-fold upon stimulation with EGF in the presence of cycloheximide (not shown). The presence of cycloheximide prevents the translation of the CAT mRNA into CAT
protein. Release from the cycloheximide-induced translational
arrest (Fig. 1C, t 5 0 min) allows efficient translation of the
accumulated CAT mRNA. The accumulation of CAT protein
increased linearly within 2 h following the washout of cycloheximide as measured by a CAT activity assay (Fig. 1C). Since
EGF was also removed from the medium together with cycloheximide, the increase of CAT activity resulted solely from
translation of the CAT mRNA that had accumulated before the
washout. Treatment of the cells with palytoxin 60 min after the
release from translational arrest resulted in a substantial decrease in CAT activity detectable both 30 and 60 min after the
addition of palytoxin (Fig. 1C). We therefore conclude that
exposure of cells to palytoxin indeed interferes with the process
of translation.
Many inhibitors of protein synthesis alter ribosomal activity
by binding directly to ribosomes (49, 50). The actions of these
inhibitors are readily detected following their addition to reticulocyte lysates that contain ribosomes and all of the necessary ingredients to allow the initiation and elongation of translation in vitro. To test whether palytoxin could inhibit protein
synthesis by directly modifying the functionality of ribosomes
in vitro, we added palytoxin to a reticulocyte lysate preparation
engaged in protein synthesis (Fig. 2). The addition to the reticulocyte lysate of mRNA for luciferase reporter protein (Fig.
2, t 5 0 min) and subsequent monitoring of luciferase activity
demonstrated the effectiveness of the lysate in promoting both
initiation and elongation. The addition of the elongation inhibitor emetine at 8 min completely blocked the further accumulation of luciferase activity. Palytoxin (30 nM) was completely
ineffective in inhibiting translation of luciferase when added
prior to the addition of luciferase mRNA. These data demonstrate that neither translational initiation nor translational
elongation were affected by the addition of palytoxin to a cellfree translational system. We therefore conclude that the inhibition of translation induced by palytoxin in vivo is unlikely to
be mediated by direct interaction between palytoxin and the
translational apparatus.
Translational Inhibitors Interfere with Palytoxin-induced
Activation of SAPK/JNK1—The demonstration that palytoxin
is a potent in vivo inhibitor of protein synthesis prompted us to
test whether palytoxin shares some of the properties of ribo-
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FIG. 2. Effect of palytoxin on the translation of luciferase
mRNA in a rabbit reticulocyte lysate assay. The mRNA for luciferase (0.5 mg), palytoxin (30 nM), or solvent (H3C)2SO was added at t 5
0 min. Emetine (10 mg/ml) was added at t 5 8 min. At designated times,
aliquots of the lysate were withdrawn and analyzed for luciferase activity. The assay was performed with a reticulocyte lysate kit, supplemented with amino acids, as described by the manufacturer (Promega).
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FIG. 3. Inhibition of the palytoxin-induced activation of SAPK/
JNK1 by pretreatment of Rat-1 cells with emetine. Serum-deprived Rat-1 cells were left untreated (lanes 1, 2, 4, and 6) or were
exposed to emetine (lanes 3, 5, 7, and 8) for 15 min prior to the addition
of palytoxin (1 nM; lanes 2 and 3), anisomycin (10 mg/ml; lanes 4 and 5),
or sorbitol (600 mM; lanes 6 and 7). Cells were harvested in lysis buffer
30 min later, and SAPK/JNK1 activity was determined by immunocomplex assay using GST-Elk-1 as substrate. Co, control cells. E, emetinetreated cells.

FIG. 4. Effect of emetine on the activation of SAPK/JNK1 by
palytoxin in Rat-1 cells. Graphic representation of the data from
immunocomplex kinase assays. Serum-deprived Rat-1 cells were
treated as follows (from left to right) with the following: solvent alone;
emetine (100 mg/ml) alone; palytoxin (1 nM) alone; or palytoxin under
conditions of prior, contemporaneous, or subsequent treatment with
emetine as denoted in the scheme (top). SAPK/JNK1 activity was determined 30 min after the addition of palytoxin.

duction of a mammalian Na1/K1-ATPase into yeast, which
demonstrated that palytoxin interacts directly with this molecule to facilitate the simultaneous entry of Na1 and exit of K1
from cells (29, 30). Since it appeared that the ribotoxic activity
of palytoxin could not be related to direct interaction with the
translational machinery, we tested whether the ribotoxic actions of palytoxin could have resulted from ionic disequilibria
produced in cells as a consequence of poisoning of the Na1/K1ATPase. To test this possibility, we conducted experiments in
which 75% of the 154 mM NaCl present in MEM culture medium was replaced by either KCl (116 mM KCl; K-MEM) or
choline chloride (116 mM; Cho-MEM). Experiments were conducted to determine whether the modified isotonic MEM containing either K1 or choline1 would reduce the ability of palytoxin to inhibit protein synthesis or to activate SAPK/JNK1.
Cells were far more sensitive to inhibition of protein synthesis
by palytoxin in MEM, compared with K-MEM, which shifted
the dose-response curve 2 decades to the right (Fig. 5). By
contrast, cells were 3-fold more sensitive in Cho-MEM than in
MEM. The ability of increased extracellular K1, but not choline1, to diminish substantially the ability of palytoxin to inhibit translation is consistent with the conclusion that efflux of
K1 may be responsible for the effects of palytoxin. The inability
of extracellular choline1 to reduce the translational inhibition
by palytoxin is consistent with the notion that influx of Na1 is
unlikely to be the cause of the effects of palytoxin.
To determine whether the potential of palytoxin to inhibit
protein translation in MEM, K-MEM, or Cho-MEM correlates
with the potential to activate SAPK/JNK1, we exposed cells to
standard or modified MEM for 30 min prior to the addition of
palytoxin. The results demonstrate that, compared with MEM,
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toxic stressors, which both activate SAPK/JNK1 and inhibit
protein translation (1). We previously showed that the activation of SAPK/JNK1 by ribotoxic stressors is rapidly suppressed
in cells whose protein synthesis had been previously blocked by
translational inhibitors that are incapable of activating SAPK/
JNK1 (1). Mediation of SAPK/JNK1-activating signals could
only occur in ribosomes that are active at the time of exposure
of ribotoxic stressors. The following experiments test whether
activation of SAPK/JNK1 by palytoxin similarly depends on
the presence of active ribosomes.
Pretreatment of cells for 15 min with emetine, an inhibitor of
translational elongation, suppressed the palytoxin-induced activation of SAPK/JNK1 measured 30 min after the addition of
palytoxin (Fig. 3, lanes 2 and 3). A similar suppression of
SAPK/JNK1 activation was observed when cells were preincubated with pactamycin, a specific inhibitor of translational
initiation (data not shown). Emetine also suppressed the activation of SAPK/JNK1 by the ribotoxic stressor anisomycin (1)
(Fig. 3, lanes 4 and 5), but not by sorbitol, an osmotic stressor
that does not act through ribosomal toxicity (1) (Fig. 3, lanes 6
and 7).
In studying the effects of ribotoxic stressors, we reported that
inhibiting protein translation by emetine as soon as 1 min prior
to the addition of anisomycin was sufficient to block transduction of the signals that lead ultimately to activation of SAPK/
JNK1 (1). This rapid action of emetine was taken as evidence
that prior inhibition of translation by emetine was unlikely to
exert its blockade of SAPK/JNK1 activation by blocking the
synthesis of a protein with rapid decay kinetics (1). The experiment presented in Fig. 4 similarly demonstrates that the addition of emetine 1 min prior to the addition of palytoxin substantially suppressed the activation of SAPK/JNK1. Emetine
failed to suppress palytoxin-induced activation of SAPK/JNK1
when emetine was added 3 min after the addition of palytoxin.
The ability of a translational inhibitor to block palytoxin-induced signaling within such a short time suggests that active
ribosomes are necessary for signal transduction and furthermore argues against the likelihood that a protein with kinetics
of rapid decay could explain the emetine-induced block to
SAPK/JNK1 activation. The inability of emetine to inhibit
SAPK/JNK1 signaling when added 3 min after the palytoxin
addition suggests that the critical ribosome-mediated events
that are required to transduce the signal have already occurred
by 3 min. These data demonstrate that, similar to ribotoxic
stressors, palytoxin requires the presence of active ribosomes
at the time of addition to activate SAPK/JNK1.
Effects of Palytoxin on Translation and Signaling in Media
Containing Modified [Na1], [K1], or [Choline1]—Several lines
of evidence indicate that the biological effects of palytoxin are
mediated through its interaction with the Na1/K1-ATPase
(28 –30). The most convincing evidence derives from the intro-
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K-MEM suppressed the ability of palytoxin to activate SAPK/
JNK1, and that cells incubated in Cho-MEM showed a more
pronounced activation of SAPK/JNK1 at equivalent palytoxin
concentrations (Fig. 6A). The cells in K-MEM were still capable
of responding to other ribotoxic and nonribotoxic stressors,
since the activity of SAPK/JNK1 was strongly elevated in cells
exposed to K-MEM containing anisomycin (a ribotoxic stressor), sorbitol, or IL-1a. (Fig. 6B). These data demonstrate that,
in addition to its diminished ability to inhibit protein translation in K-MEM, palytoxin was also unable to activate SAPK/
JNK1. These data also demonstrated that the inability of palytoxin to activate SAPK/JNK1 in K-MEM does not result from
the general inhibition by K-MEM of pathways leading to
SAPK/JNK1 activation.
We next tested whether cells exposed to palytoxin in K-MEM
were capable of responding to the toxin when transferred from
K-MEM to standard MEM (Fig. 7). The increase in SAPK/
JNK1 activity in cells exposed for 30 min to 0.1 nM palytoxin in
standard MEM was inhibited in K-MEM (Fig. 7, lanes B and
D). When cells incubated for 30 min in K-MEM containing
palytoxin were rinsed with palytoxin-free K-MEM and transferred to standard MEM without palytoxin (Fig. 7, lane F),
SAPK/JNK1 activity was increased to at least the same levels
achieved by palytoxin in standard MEM. These data suggest
that K-MEM impeded the transduction of a signal generated by
palytoxin; shifting cells to standard MEM supplied the conditions necessary to complete transduction of the signal that
leads to the activation of SAPK/JNK1. The increase in SAPK/
JNK1 activity following the exchange of K-MEM for standard
MEM again suggests that K1 efflux may be responsible for initiating the activation of SAPK/JNK1 in palytoxin-treated cells.
DISCUSSION

The ability of palytoxin to both inhibit protein synthesis and
stimulate SAPK/JNK1 activity (Fig. 1) led us to investigate
whether palytoxin acts as a ribotoxic stressor. Previously identified ribotoxic stressors share the following characteristics: (i)
they inhibit translational elongation by interacting directly
with 28 S rRNA in the region of the peptidyl transferase center
or the S/R loop; (ii) they rapidly induce the activation of the
stress kinases SEK1/MKK4, SAPK/JNK1, and p38/HOG1; and
(iii) they induce the activation of stress kinases only in cells
that contain actively translating ribosomes (1). Other nonribo-

FIG. 6. Effect of palytoxin and other agents on SAPK/JNK1
activation following the replacement of Na1 in MEM by K1 or
choline. A, effect of palytoxin on SAPK/JNK1 activation. Serum-deprived Rat-1 cells were incubated in MEM, K-MEM, or Cho-MEM (as in
Fig. 5) for 10 min prior to the addition of varying doses of palytoxin.
Thirty min later, cells were harvested, and the lysate was analyzed for
activated SAPK/JNK1 by an immunocomplex assay. The PhosphorImager data is displayed in the lower part; the graphic representation of
this data is displayed in the upper part. B, effectiveness of several
agents to activate SAPK/JNK1 following replacement of Na1 in MEM
by K1 or choline1. The experiment is similar to the one presented in A.
Cells were incubated in MEM, K-MEM, or Cho-MEM and exposed to
palytoxin (0.1 nM), anisomycin (10 mg/ml), sorbitol (600 mM) for 30 min
or to IL-1a (25 ng/ml) for 10 min prior to harvesting and analysis of
SAPK/JNK1 activation by the immunocomplex assay.

toxic stressors that activate stress kinases, such as proinflammatory cytokines and osmotic stress, are distinguished from
ribotoxic stressors by their ability to induce signaling to the
stress kinases even in the absence of translationally active
ribosomes. Although experiments demonstrated that palytoxin
was ineffective as a translational inhibitor when added directly
to actively translating ribosomes in vitro (Fig. 2), palytoxin
nevertheless required translating ribosomes to transduce signals that activate SAPK/JNK1 in vivo. The rapid inhibition of
SAPK/JNK1 activation by emetine, which substantially
blocked the activation when added just 1 min prior to palytoxin
(Fig. 3), was also observed when emetine was added just prior
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FIG. 5. Effect of palytoxin on the incorporation of [3H]leucine
following replacement of Na1 in MEM by K1 or choline1. Serumdeprived Rat-1 cells were incubated in standard MEM (containing 154
mM Na1) or in MEM containing 38 mM Na1 and 116 mM of either K1
(K-MEM) or choline1 (Cho-MEM). After the addition of varying concentrations of palytoxin, cells were pulse-labeled with 5 mCi/ml [3H]leucine
from 10 to 20 min. S.D. was obtained from experimental points in
triplicate.
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FIG. 7. Activation of SAPK/JNK1 when Rat-1 cells incubated in
K-MEM plus palytoxin are postincubated in MEM without palytoxin. A, cells were incubated in MEM for 75 min. B, cells were
incubated in MEM for 15 min prior to the addition of palytoxin for an
additional 60 min. C, cells were incubated in K-MEM for 75 min. D, cells
were incubated in K-MEM for 15 min prior to the addition of palytoxin.
E, cells were incubated in K-MEM for 45 min; cells were then rinsed
several times in K-MEM and placed into fresh MEM for an additional
30 min. F, cells were incubated in K-MEM for 15 min prior to the
addition of palytoxin. At 45 min, the medium was removed, cells were
rinsed several times in palytoxin-free K-MEM, and fresh MEM was
added for an additional 30 min. All cells were harvested at 75 min, and
cell lysates were analyzed for activation of SAPK/JNK1 by an immunocomplex assay. Palytoxin (PT) was added at 0.1 nM.

to ribotoxic stressors such as anisomycin and ricin (1). The
rapid action of emetine in this context suggests that actively
translating ribosomes are required for palytoxin-initiated signals to be transduced to the kinase(s) upstream of SEK1/MKK4
and SAPK/JNK1. That cells exposed to palytoxin became refractory to emetine when emetine was added 3 min after palytoxin suggests that the critical events of ribosome-mediated
transduction are completed by 3 min. A similar time course was
observed for anisomycin (1).2 Since the effects of palytoxin
2
M. S. Iordanov, D. Pribnow, J. L. Magun, J. A. Pearson, T.-H. Dinh,
and B. E. Magun, submitted for publication.
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